EVLO (Evelo Biosciences) Payments of Debt: $-47.61 Mil (TTM As of Sep. 2023)


What is Evelo Biosciences Payments of Debt?

Evelo Biosciences EVLO -99.00% Payments of Debt is $-47.61 Mil as of Sep. 2023.

Evelo Biosciences's Payments of Debt for the three months ended in Sep. 2023 was $0.00 Mil.

Evelo Biosciences's Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2023 was $-47.61 Mil.


Evelo Biosciences Payments of Debt Related Terms


Evelo Biosciences Payments of Debt Historical Data

* Premium members only.

The historical data trend for Evelo Biosciences's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evelo Biosciences Payments of Debt Chart

Evelo Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Payments of Debt
Get a 7-Day Free Trial 0.00 -15.00 0.00 0.00 -47.61

Evelo Biosciences Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -47.61 0.00 0.00 0.00

Evelo Biosciences Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-47.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-47.61 Mil mean?
Evelo Biosciences (EVLO) has a Payments of Debt of $-47.61 Mil as of Sep. 2023. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Evelo Biosciences and its competitors.
Is Evelo Biosciences' Payments of Debt too high?
Evelo Biosciences' current Payments of Debt is $-47.61 Mil.
How does Evelo Biosciences' Payments of Debt compare to IMNN and EDSA?
Evelo Biosciences' Payments of Debt of $-47.61 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Evelo Biosciences and its competitors. Evelo Biosciences's current Payments of Debt is $-47.61 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evelo Biosciences stock overvalued right now?
Evelo Biosciences (EVLO) has a current Payments of Debt of $-47.61 Mil. The current Payments of Debt is $-47.61 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Evelo Biosciences (EVLO), the current Payments of Debt is $-47.61 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evelo Biosciences Business Description

Address 620 Memorial Drive, Cambridge, MA, USA, 02139
Evelo Biosciences Inc is a clinical-stage biotechnology company focused on discovering and developing a new class of oral medicines that act on immune cells in the small intestine with systemic effects. The company is developing EDP1815 as a treatment in psoriasis and atopic dermatitis and EDP2939 in psoriasis.